Abstract
Individual lifestyle factors moderately impact the gut microbiome and host biology. This study explores whether their combined influence significantly alters the gut microbiome and determines the mediating role of the gut microbiome in the links between lifestyle and phenomes. Analyzing 1,643 individuals from the Metacardis European study, we created a non-exhaustive composite lifestyle score (QASD score) incorporating diet quality and diversity, physical activity and smoking. This score shows higher explanatory power for microbiome composition variation compared to individual lifestyle variables. It positively associates with microbiome gene richness, butyrate-producing bacteria, and serum metabolites like Hippurate linked metabolic health. It inversely associates with Clostridium bolteae and Ruminococcus gnavus, serum branched-chain amino acids and dipeptides observed in chronic diseases. Causal inference analyses found 135 cases where the microbiome mediates >20% of QASD score effects on host metabolome. Microbiome gene richness also emerged as a strong mediator in the QASD score’s impact on markers of host glucose metabolism (27.3% of the effect on HOMA- IR), despite bidirectional associations between the microbiome and clinical phenotypes. This study emphasizes the importance of combining lifestyle factors to understand their collective contribution to the gut microbiota and the mediating effects of the gut microbiome on the impact of lifestyle on host metabolic phenotypes and metabolomic profiles.
Competing Interest Statement
The authors have declared no competing interest.
Clinical Protocols
Funding Statement
This work was supported by European Union s Seventh Framework Programme for research technological development and demonstration under grant agreement HEALTH-F4-2012-305312 (METACARDIS). Funding supports were also obtained from Leducq Foundation(17CVD01), JPI-Microdiet study (2017-01996_3). Part of the work was supported by a grant from the Deutsche Forschungsgemeinschaft (DFG): SFB 1052 (project B1) the Fondation pour la Recherche Medicale (FDT201904008276 FDT202106012793) and the French Agency of Research (ANR-CAPTOR, ANR-DeepIntegromics)
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
The study protocol was approved by the Ethics Committee at the Medical Faculty at the University of Leipzig Germany (application number: 047-13-28012013) the ethical committees of the Capital Region of Denmark (H-3-2013-145) and the ethics committee Comite de Protection des Personnes (CPP) Ile-de-France III no.IDRCB2013-A00189-36 in France and was registered at https://clinicaltrials.gov/ (NCT02059538). The observational cohort design complied with all relevant ethical regulations, aligning with the Helsinki Declaration and in accordance with European privacy legislation. All participants provided written informed consent.
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Footnotes
One Sentence Summary: The gut microbiome mediates the impact of Diet quality and diversity, physical activity and smoking status —combined in a composite lifestyle score— on several cardiometabolic phenotypes
↵† MetaCardis Collaborators The MetaCardis consortium: Rohia Alili, Renato Alves, Ehm Astrid Andersson Galijatovic, Olivier Barthelemy, Jean-Philippe Bastard, Jean-Paul Batisse, Pierre Bel Lassen, Randa Bittar, Hervé Blottière, Frederic Bosquet, Olivier Bourron, Mickael Camus, Cecile Ciangura, Jean-Philippe Collet, Arne Dietrich, Morad Djebbar, Angélique Doré, Line Engelbrechtsen, Leopold Fezeu, Sebastien Fromentin, Marianne Graine, Caroline Grünemann, Agnes Hartemann, Bolette Hartmann, Gerard Helft, Malene Hornbak, Julien Chilloux, Antonis Myridakis, Lesley Hoyles, Richard Isnard, Sophie Jaqueminet, Niklas Rye Jørgensen, Hanna Julienne, Johanne Justesen, Judith Kammer, Nikolaj Karup, Lars Køber, Michael Kuhn, Véronique Lejard, Ivica Letunic, Florence Levenez, Lajos Marko, Laura Martinez-Gili Robin Massey, Nicolas Maziers, Lucas Moitinho-Silva, Gilles Montalescot, Ana Luisa Neves, Michael Olanipekun, Laetitia Pasero Le Pavin, Luis Pedro Coelho, Andrea Rodriguez-Martinez, Christine Rouault, Sebastien Schmidt, Tatjana Schütz, Lucas Silva, Johanne Silvain, Mathilde Svendstrup, Thierry Vanduyvenboden, Eric O Verger, Stefanie Walthe.
Hello, the article was revised and replaces this version: MS ID#: MEDRXIV/2024/301195 Authors and text were corrected. Thanks
Data availability
Raw shotgun sequencing data that support the findings of this study have been deposited in the European Nucleotide Archive with accession codes PRJEB37249, PRJEB38742, PRJEB41311, PRJEB46098 and PRJEB71898, with public access. Metabolome data have been uploaded to Metabolights and MassIVE with respective accession numbers—that is, serum NMR and urine NMR with accession number MTBLS3429.